The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.
 
Soha Bazyar
No Relationships to Disclose
 
Philip Sutera
Employment - Catalent (I)
Stock and Other Ownership Interests - Catalent (I); Merck; Pfizer
 
Ryan Phillips
(OPTIONAL) Uncompensated Relationships - Veracyte
 
Mathew Pierre Deek
No Relationships to Disclose
 
Noura Radwan
No Relationships to Disclose
 
Catherine Handy Marshall
Consulting or Advisory Role - Bayer; Dendreon; McGraw-Hill Education; Obseva
Patents, Royalties, Other Intellectual Property - McGraw Hill - textbook royalties
Travel, Accommodations, Expenses - Bayer
 
Mark V. Mishra
Employment - Orthofix (I)
Stock and Other Ownership Interests - Adverum
 
Zaker Hamid Rana
No Relationships to Disclose
 
Jason K. Molitoris
No Relationships to Disclose
 
Young Kwok
No Relationships to Disclose
 
Santosh Gupta
No Relationships to Disclose
 
Alisa Tubbs
Employment - Epic Sciences
 
Rick Wenstrup
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - Blueprint Genetics; Resolys Bio
Patents, Royalties, Other Intellectual Property - Assurex Health; Patent royalties
Travel, Accommodations, Expenses - Epic Systems
 
Theodore L. DeWeese
Stock and Other Ownership Interests - Digital Harmonic
Patents, Royalties, Other Intellectual Property - patent pending on computer algorithm in radiation therapy planning
 
Daniel Y. Song
No Relationships to Disclose
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Kenneth J. Pienta
Leadership - CUE Biopharma; Keystone Biopharma
Stock and Other Ownership Interests - CUE Biopharma; Keystone Biopharma; Medsyn Biopharma; Oncopia Therapeutics
Consulting or Advisory Role - Akrevia Therapeutics; CUE Biopharma; GloriousMed Technology
Research Funding - Progenics
Travel, Accommodations, Expenses - CUE Biopharma
 
Emmanuel S. Antonarakis
Honoraria - AIkido Pharma; Amgen; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Celgene; Clovis Oncology; Constellation Pharmaceuticals; Curium Pharma; Dendreon; ESSA; Exact Sciences; Foundation Medicine; GlaxoSmithKline; InVitae; ISMAR Health Care; Janssen Biotech; Lilly; Medivation; Merck; Orion; Sanofi; Tempus
Consulting or Advisory Role - AIkido Pharma; Amgen; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clovis Oncology; Constellation Pharmaceuticals; Curium Pharma; Dendreon; ESSA; Exact Sciences; Foundation Medicine; GlaxoSmithKline; InVitae; ISMAR Health Care; Janssen Biotech; Lilly; Medivation; Merck; Orion; Sanofi; Tempus
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Celgene; Clovis Oncology; Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Ana Ponce Kiess
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - POINT Biopharma
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Health; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical